Skip to content

Operative Versus Non Operative Management Outcomes of Isolated Lateral Malleolar Weber B Ankle Fractures

Operative Versus Non Operative Management Outcomes of Isolated Lateral Malleolar Weber B Ankle Fractures

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03625154
Enrollment
200
Registered
2018-08-10
Start date
2018-09-01
Completion date
2020-12-30
Last updated
2018-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Fractures

Brief summary

The primary objective of this study is to determine the failure rate and difference in clinical outcomes between operative and non operative treatment of patients with Weber B lateral malleolus ankle fractures with medial clear space widening on gravity stress views. All patients presenting will be treated non operatively, and compared to an observational group comprised of patients with Weber B lateral malleolus ankle fractures without medial clear space widening, for which the standard of care is non operative management. Patients who decline non operative management and elect to undergo operative open reduction internal fixation with plates and screws will comprise an operative observational cohort. All patients will be followed for a total of 12 months from the time of injury. Clinical outcomes will be based on radiographic monitoring for ankle mortise congruency, as well as standardized SF-36 and AOFAS questionnaire scores.

Interventions

PROCEDUREankle open reduction internal fixation

Open Reduction and Internal Fixation with plates and screws

closed reduction and splinting followed by progressive weight bearing

Sponsors

Cedars-Sinai Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-65 years old * able to provide informed consent

Exclusion criteria

* pregnancy * prisoners * psychiatric conditions that prevent ability to provide informed consent or present barriers to follow up * insulin dependent diabetics * patients with prior musculoskeletal issues affecting the same extremity * Patients cannot simultaneously be enrolled in any other studies.

Design outcomes

Primary

MeasureTime frameDescription
radiographic outcome of ankle congruency1 yearmeasurement of medial clear space between medial malleolus and medial talar dome, measurement of tibiofibular overlap 1cm superior to the plafond, and measurement of superior clear space between the tibial plafond and the talar dome

Secondary

MeasureTime frameDescription
functional outcome by American Orthopedic Foot and Ankle Score (AOFAS) scoring system1 yeartotal score 0-100, with 100 being the maximum best score. (pain (0-40 points), function (0-50 points) and alignment (0-10 points)
additional functional outcome by Short Form Survey (SF-36) Score scoring system1 year0 to 100 range, 100 being the best; subscores Physical functioning (0-10), Role limitations due to physical health (0-4), Role limitations due to emotional problems (0-3), Energy/fatigue (0-4)Emotional well-being (0-5), Social functioning (0-2), Pain (0-2), General Health 0-5
functional outcome by American Orthopedic Foot and Ankle Score (AOFAS) - Pain score1 yearnone, mild occasional, moderate daily, severe and almost always present
functional outcome by American Orthopedic Foot and Ankle Score (AOFAS) - function - activity limitations, support requirements1 yearno limitations and no support, no limitation of daily activities but limitation of recreational activities, limited daily and recreational activities, or severe limitation of daily and recreational activities
functional outcome by American Orthopedic Foot and Ankle Score (AOFAS) - alignment1 yeargood plantigrade, midfoot well aligned; fair plamtigrade, some degree of midfoot malalignment, poor with nonplantigrade foot, severe malalignment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026